Titlebook: Resistance to Immunotoxins in Cancer Therapy; Rama Shanker Verma,Benjamin Bonavida Book 2015 Springer International Publishing Switzerland

bradycardia

書目名稱Resistance to Immunotoxins in Cancer Therapy影響因子(影響力)




書目名稱Resistance to Immunotoxins in Cancer Therapy影響因子(影響力)學(xué)科排名




書目名稱Resistance to Immunotoxins in Cancer Therapy網(wǎng)絡(luò)公開度




書目名稱Resistance to Immunotoxins in Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Resistance to Immunotoxins in Cancer Therapy被引頻次




書目名稱Resistance to Immunotoxins in Cancer Therapy被引頻次學(xué)科排名




書目名稱Resistance to Immunotoxins in Cancer Therapy年度引用




書目名稱Resistance to Immunotoxins in Cancer Therapy年度引用學(xué)科排名




書目名稱Resistance to Immunotoxins in Cancer Therapy讀者反饋




書目名稱Resistance to Immunotoxins in Cancer Therapy讀者反饋學(xué)科排名

Hamper

2196-5501 ance in immunotoxin drugs.Discusses an array of immune respo.This book will be a guide to understanding resistance against targeted therapeutic approaches for cancer using immunotoxins. It contains a detailed review of the history and development of targeted therapy. As well, it includes an in-depth

ablate

Book 2015ed in cancer resistance and several novel methods to overcome resistance. Each chapter discusses different aspects of resistance and covers all the factors that may contribute to resistance in cancer cells. Finally, this volume highlights the recent findings and advances associated with tackling cancer resistance..

patriarch

exostosis

Targeted Cancer Therapy: History and Development of Immunotoxins, drug resistance and toxic side effects. One relatively new approach for treatment is immunotherapy, using antibodies or ligands to cell surface molecules as vehicles to deliver toxins to specific cells, thus increasing the efficacy of the treatment by several folds. Such conjugates, of antibodies a

insecticide

笨重

Factors that Determine Sensitivity and Resistances of Tumor Cells Towards Antibody-Targeted Proteinsylation and are potent antitumoral agents in clinical development. The sensitivity of tumor cells towards such fusion proteins, and hence their therapeutic efficacy, is influenced by multiple factors: (i) access to tumor cells, (ii) target antigen binding and internalization, (iii) entry into the c

Ferritin

證實(shí)

iodides